Liver Failure and Liver Disease

You have full text access to this OnlineOpen article

Quality of life in refractory ascites: Transjugular intrahepatic portal-systemic shunting versus medical therapy†

  1. Mical S. Campbell1,
  2. Colleen M. Brensinger2,
  3. Arun J. Sanyal3,
  4. Chris Gennings4,
  5. Florence Wong5,
  6. Kris V. Kowdley6,
  7. Timothy McCashland7,
  8. K. Rajender Reddy1,‡,*

Article first published online: 17 AUG 2005

DOI: 10.1002/hep.20840

Issue

Hepatology

Hepatology

Volume 42, Issue 3, pages 635–640, September 2005

Additional Information

How to Cite

Campbell, M. S., Brensinger, C. M., Sanyal, A. J., Gennings, C., Wong, F., Kowdley, K. V., McCashland, T. and Reddy, K. R. (2005), Quality of life in refractory ascites: Transjugular intrahepatic portal-systemic shunting versus medical therapy. Hepatology, 42: 635–640. doi: 10.1002/hep.20840

Author Information

  1. 1

    Division of Gastroenterology, University of Pennsylvania Health Services, Philadelphia, PA

  2. 2

    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA

  3. 3

    Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA

  4. 4

    Department of Biostatistics, Virginia Commonwealth University, Richmond, VA

  5. 5

    Department of Medicine, University of Toronto, Toronto, Ontario, Canada

  6. 6

    Department of Internal Medicine, University of Washington, Seattle, WA

  7. 7

    Department of Internal Medicine, University of Nebraska, Omaha, NE

  1. ‡

    fax: (215) 349-5915

*Division of Gastroenterology, 3 Ravdin, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 22 AUG 2005
  2. Article first published online: 17 AUG 2005
  3. Manuscript Accepted: 21 JUN 2005
  4. Manuscript Received: 30 MAR 2005

Funded by

  • National Institutes of Health. Grant Numbers: R01 DK 51523, M01-RR-00065

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (116K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kevin Korenblat, Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 2012,

    CrossRef

  2. 2
    A. Sanyal, Z. M. Younossi, N. M. Bass, K. D. Mullen, F. Poordad, R. S. Brown, R. P. Vemuru, M. Mazen Jamal, S. Huang, K. Merchant, E. Bortey, W. P. Forbes, Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy – a double-blind placebo-controlled study, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
    Direct Link:
  3. 3
    EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, Journal of Hepatology, 2010, 53, 3, 397

    CrossRef

  4. 4
    Shandya Bridget Decruze, Robert Macdonald, Gillian Smith, Jonathan J. Herod, Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites, Journal of Palliative Medicine, 2010, 13, 3, 251

    CrossRef

  5. 5
    Kurt Lenz, Therapierefraktärer Aszites, DoctorConsult - The Journal. Wissen für Klinik und Praxis, 2010, 1, 3, e195

    CrossRef

  6. 6
    Jonathan M. Buscaglia, Xavier Dray, Eun Ji Shin, Priscilla Magno, Kevin M. Chmura, Vihar C. Surti, Travis E. Dillon, Richard W. Ducharme, Gianfranco Donatelli, Paul J. Thuluvath, Samuel A. Giday, Sergey V. Kantsevoy, A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video), Gastrointestinal Endoscopy, 2009, 69, 4, 941

    CrossRef

  7. 7
    D. Lebrec, R. Moreau, Prise en charge de l’ascite réfractaire par l’anastomose portosystémique intrahépatique (TIPS), Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 717

    CrossRef

  8. 8
    J. J. KUIPER, R. A. DE MAN, H. R. VAN BUUREN, Review article: management of ascites and associated complications in patients with cirrhosis, Alimentary Pharmacology & Therapeutics, 2007, 26,
    Direct Link:
  9. 9
    Luis Colombato, The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension, Journal of Clinical Gastroenterology, 2007, 41, Supplement 3, S344

    CrossRef

  10. 10
    M. Senzolo, P. Burra, E. Cholongitas, F. Lodato, L. Marelli, P. Manousou, D. Patch, G.C. Sturniolo, A.K. Burroughs, The transjugular route: The key hole to the liver world, Digestive and Liver Disease, 2007, 39, 2, 105

    CrossRef

  11. 11
    Guadalupe Garcia-Tsao, Portal hypertension, Current Opinion in Internal Medicine, 2006, 5, 4, 399

    CrossRef

  12. 12
    M.S. Campbell, Quality of Life in Refractory Ascites: Transjugular Intrahepatic Portal-Systemic Shunting Versus Medical Therapy, Yearbook of Gastroenterology, 2006, 2006, 261

    CrossRef

  13. 13
    Guadalupe Garcia-Tsao, The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites, Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3, 7, 380

    CrossRef

  14. 14
    Marco Senzolo, Evangelos Cholongitas, Jonathan Tibballs, Andrew Burroughs, David Patch, Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome, European Journal of Gastroenterology & Hepatology, 2006, 1143

    CrossRef

  15. 15
    Praveena G. Velamati, H. Franklin Herlong, Treatment of refractory ascites, Current Treatment Options in Gastroenterology, 2006, 9, 6, 530

    CrossRef

View Full Article (HTML) Get PDF (116K)